The regulatory file for L-aspartic acid
L-Aspartic acid is supplied as the free acid, CAS 56-84-8. The catalog specification describes the material; the regulatory file is built around the destination, the intended use and the finished product. The buyer's regulatory team confirms the route. This page lists the documents and checks that belong in the file, so the specification and the commercial pack can be reviewed together.
The specification describes the powder; the regulatory file shows which route, which limits and which label apply where it will be sold.
What the file contains
A complete file answers four practical questions. What is the material, and which specification revision is being bought? Which lot is being released, and what does its certificate report? Which limits and label rules apply to the finished product? And what changes if the source, the process or the pack changes? The certificate of analysis answers the lot question, the technical data sheet answers the specification question, and the safety data sheet answers the handling question. None of them answers the route question on its own.
The file should also hold the allergen and GMO statements, the origin record, the residual-solvent statement and a statement that the material is the L enantiomer, supported by the specific rotation on the certificate. Where a statement is not available for the lot, the gap should be named before the order, not discovered at the port. A document list with version numbers is more useful than a folder of undated PDFs.
European Union
The EU file is built from the specification, the contaminant results and the label. General food law (Regulation (EC) No 178/2002), labelling (Regulation (EU) No 1169/2011) and the contaminants regulation (Regulation (EU) 2023/915, as amended) apply alongside the route for the intended use. For a food supplement, Directive 2002/46/EC and its national implementation set the framework. The current consolidated text is the reference, not a summary, and the buyer's regulatory team confirms the route for the destination member state.
An amino acid does not have one route. Food, food supplement, flavouring and additive uses are assessed on different instruments, and a chemically similar amino acid does not inherit another's position. The additive route is written around named entries; it is not a generic permission for the amino acid family, and L-aspartic acid has to be assessed on its own intended use. The additive route is not a substitute for the supplement route.
Great Britain and Northern Ireland are checked separately. The GB file uses the current GB register and GB labelling rules; Northern Ireland follows the EU framework. The buyer confirms which of the two applies and keeps the evidence with the order.
United States
The US file is built around the exact dietary ingredient or food substance and its intended use. For a supplement, the route turns on the dietary-ingredient basis, the Supplement Facts panel under 21 CFR 101.36 and the current good manufacturing practice record under 21 CFR 111. For a food use, the basis is a different one. The supplier should be able to name the basis it relies on and point to the supporting document; the buyer confirms that the basis covers the finished product and the claim.
The certificate is not an authorisation. It reports the lot against a specification, and the label and the claim are reviewed separately. The US regulatory note sets out the framework; the route for a particular product remains a decision for the buyer's regulatory team.
Contaminants and limits
The contaminant panel is a finished-product calculation, not only a drum result. The table below is the usual starting point for a food-supplement file; the current destination text and the daily dose decide the final limit.
| Parameter | Typical supplement reference | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Lot result, method and the finished-product calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Lot result and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Lot result and method |
| Arsenic (As) | Customer or market limit | The agreed limit and the method, stated on the certificate |
The arithmetic is simple and often left out. At a 1,000 mg daily dose of aspartic acid, a 3.0 mg/kg lead limit allows 3 µg of lead per day from this ingredient: 3 mg/kg multiplied by 0.001 kg. The result is a share of the finished product's allowance, not the whole of it, and the excipients add their own contribution. The file should show that calculation next to the lot result.
Label and claims
The label names the material in the form the destination requires. “L-aspartic acid” is the ingredient; “aspartic acid” without the enantiomer is ambiguous where the L form is the claim, and a salt has a different name again. The claim review is separate: the brand's regulatory reviewer confirms that the wording is allowed for the product, the form and the market. There is no disease-related claim on this material, and the certificate does not approve a claim.
If a structure or function wording is used, it needs substantiation and the destination's own rules, and the reviewer signs it off against the finished product rather than against the drum. A claim does not change the specification, and a specification change does not carry a claim with it.
Documents for the file
The core set is the specification with its revision, the COA for the lot, the technical data sheet and the safety data sheet. The supporting set is the allergen statement, the GMO statement, the origin record, the residual-solvent statement, the enantiomer statement and the contaminant results. A packaging statement and a declaration of any irradiation treatment belong in the file where the destination asks for them.
Each document should carry the product name, the form, the CAS number and a version or lot reference, so that the quotation, the specification and the certificate can be read as one set. The COA page explains the release document; the identity page covers the L/D evidence; the quality page describes the release file.
Checklist before the first order
- Specification version, CAS 56-84-8 and the L form are named.
- COA, TDS, SDS, allergen, GMO, origin and residual-solvent statements are on file.
- The enantiomer statement is supported by the specific rotation, not only by the product name.
- The contaminant results are converted to the finished-product dose.
- The label and the claim have been reviewed for the destination.
- The source, process and pack are under change control.
The product hub carries the catalog specification, and the EU regulatory note provides the framework references for the file.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation